The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate

European Journal of Pharmacology

Volumn 428, Issue 1, 2001, Pages 37-44

  Santos, Natacha C F ^a   Castilho, Roger F ^b   Meinicke, André R ^b   Hermes Lima, Marcelo ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Free radical; Iron chelator; Lipid peroxidation; Mitochondria; Oxidative stress; Pyridoxal isonicotinoyl hydrazone

Indexed keywords

ANTIMYCIN A1; ANTIOXIDANT; FERROUS CITRATE FE 59; FERROUS ION; OXYGEN; PYRIDOXAL ISONICOTINOYLHYDRAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IRON CHELATION; IRON OVERLOAD; LIPID PEROXIDATION; LIVER MITOCHONDRION; MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; CHELATING AGENTS; FERRIC COMPOUNDS; INDICATORS AND REAGENTS; IRON; IRON CHELATING AGENTS; ISONIAZID; LIPID PEROXIDATION; MEMBRANE POTENTIALS; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PYRIDOXAL; RATS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0035964737     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01291-2     Document Type: Article

References (38)

1. Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone
2. Lipid peroxidation in mitochondria
3. Mechanisms of iron toxicity
4. The lag phase
5. Mitochondrial function is differentially affected upon oxidative stress
6. Mitochondrial damage and its role in causing hepatocyte injury during stimulation of lipid peroxidation by iron nitriloacetate
7. 2+ and includes lipid peroxidation and alterations in membrane proteins
8. The role of Fe(III) in Fe(II)-citrate-mediated peroxidation of mitochondrial membrane lipids
9. Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death
10. The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders
11. Friedreich's ataxia and iron metabolism
12. Mitochondria and apoptosis
13. Antioxidant defences
14. 2+ and 5-aminolulinic acid-derived oxyradicals promote injury to isolated mitochondria?
15. Deoxyribose degradation catalyzed by Fe(III)EDTA: Kinetic aspects and potential usefulness for submicromolar iron measurements
16. Characteristics of Fe(II)ATP complex-induced damage to the rat liver mitochondria
17. •OH-mediated strand breaks
18. •OH formation by the Fenton reaction
19. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate
20. Iron chelators
21. Iron ion induces mitochondrial DNA damage in HTC rat hepatoma cell culture: Role of antioxidants in mitochondrial DNA protection from oxidative stresses
22. The efficiencies of the component steps of oxidative phosphorylation: II. Experimental determination of the efficiencies in mitochondria and examination of the equivalence of membrane potential and pH gradient in phosphorylation
23. Autoxidation of ferrous ion complexes: A method for the generation of hydroxyl radicals
24. Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: Mitochondrial function in cultured, iron-loaded heart cells
25. Iron homeostasis, oxidative stress, and DNA damage
26. 2+-dependent lipid peroxidation
27. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis
28. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents: II. The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone
29. Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism
30. Pyridoxal isonicotinoyl hydrazone and its analogues: Potential orally effective iron chelating agents for the treatment of iron overload disease
31. In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogs
32. Genetic disorders affecting proteins of iron metabolism: Clinical implications
33. Demyelination: The role of reactive oxygen and nitrogen species
34. Toxicological study of pyridoxal isonicotinoyl hydrazone: Acute and subchronic toxicity
35. Iron as a hepatotoxin
36. Mitochondrial targets of drug toxicity
37. Pyridoxal isonicotinoyl hydrazone (PIH): A promising new iron chelator